Background Although breast cancer during pregnancy (BCDP) is rare (occurring with only
0.4% of all BC diagnoses in female patients aged 16–49 years), management decisions are …

OBJECTIVE: To examine the risk of birth defects in children born to women who used
ondansetron early in pregnancy for nausea and vomiting of pregnancy or hyperemesis …

Migraine is a common and potentially disabling disorder for patients, with wide-reaching
implications for health care services, society, and the economy. Nausea and vomiting during …

Aims. Nausea and vomiting of pregnancy is the most common medical condition in
pregnancy. There is an increasing trend to prescribe ondansetron although its safety for use …

Background Maternal undernutrition during pregnancy disrupts both fetal growth and
development with perturbations to certain physiological processes within the maternal-fetal …

Background. Nausea and vomiting of pregnancy (NVP) is the most common medical
condition of pregnancy, affecting up to 85% of expecting mothers. In the USA, there is no …

Most pregnant women will experience some degree of nausea or vomiting during
pregnancy. Dietary and lifestyle interventions, along with appropriate drug treatment, can …

The aim of this study was to develop a simple, rapid and efficient reversed phase HPLC-UV
method for ondansetron assay in injectable dosage forms. Material and methods: Analyses …

Background: Pregnancy-related nausea and vomiting or morning sickness with an overall
prevalence rate of 80% is commonly appeared at the eighth week and frequently …

Background: Ondansetron It is a 5-HT3 serotonin receptor antagonist that is used to prevent
nausea and vomiting caused by cancer chemotherapy, radiotherapy, and surgery, as well as …